Good Research Practices for Measuring Drug Costs in Cost Effectiveness Analyses: An Industry Perspective: The ISPOR Drug Cost Task Force Report—Part V

J. Mycka, Renato Dellamano, Eugene Mick Kolassa, Michael Wonder, Sabyasachi Ghosh, Joel W. Hay, Jim Smeeding

Value in Health · 2009 · 14 citations · 0 references

DOIFull text

Open access

Concepts